Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
J Pers Med ; 12(7)2022 Jun 30.
Article in English | MEDLINE | ID: mdl-35887581

ABSTRACT

In recent years, patient-specific spinal drill guides (3DPGs) have gained widespread popularity. Several studies have shown that the accuracy of screw insertion with these guides is superior to that obtained using the freehand insertion technique, but there are no studies that make a comparison with computer-assisted surgery (CAS). The aim of this study was to determine whether the accuracy of insertion of spinal screws using 3DPGs is non-inferior to insertion via CAS. A randomized controlled split-spine study was performed in which 3DPG and CAS were randomly assigned to the left or right sides of the spines of patients undergoing fixation surgery. The 3D measured accuracy of screw insertion was the primary study outcome parameter. Sixty screws inserted in 10 patients who completed the study protocol were used for the non-inferiority analysis. The non-inferiority of 3DPG was demonstrated for entry-point accuracy, as the upper margin of the 95% CI (−1.01 mm−0.49 mm) for the difference between the means did not cross the predetermined non-inferiority margin of 1 mm (p < 0.05). We also demonstrated non-inferiority of 3D angular accuracy (p < 0.05), with a 95% CI for the true difference of −2.30°−1.35°, not crossing the predetermined non-inferiority margin of 3° (p < 0.05). The results of this randomized controlled trial (RCT) showed that 3DPGs provide a non-inferior alternative to CAS in terms of screw insertion accuracy and have considerable potential as a navigational technique in spinal fixation.

2.
Clin Neuropathol ; 41(5): 211-218, 2022.
Article in English | MEDLINE | ID: mdl-35575415

ABSTRACT

This case report concerns a 31-year-old male with an aggressive pituitary tumor who presented initially with bitemporal hemianopsia and slightly elevated prolactin. On magnetic resonance imaging of the brain, there was a sellar mass with parasellar invasion to the lateral aspects of the internal carotid arteries, compressing the optic chiasm. On histopathological analysis, the diagnosis was made of a densely granulated lactotroph pituitary tumor with a Ki67 proliferation rate of 15%, a mitotic count of 6/10 high-power fields, and p53 positivity. Based on these features, the tumor was classified as a grade 2b tumor according to the Trouillas classification, and a more aggressive behavior of the tumor could be expected. In order to anticipate a future need for alternative drug treatments, the following analyses were undertaken: MGMT methylation (present) as well as the expression of estrogen receptor (negative), programmed-death ligand 1 (60 - 70% positive tumor cells), vascular endothelial growth factor-A and somatostatin receptor 2 (both positive). There was regrowth of residual tumor tissue, and the treatment consisted thus far of repeat surgery, cabergoline, pasireotide, and radiotherapy. Chemotherapy with temozolomide could not yet be initiated due to a concurrent infertility treatment. This case is unique because the tumor displays atypical characteristics, both in terms of morphology and behavior. It also illustrates how pathologists can play an important role in determining the diagnosis, prognosis, and possibilities for targeted therapy.


Subject(s)
Lactotrophs , Pituitary Neoplasms , Adult , Cabergoline/therapeutic use , Humans , Ki-67 Antigen , Lactotrophs/pathology , Male , Pituitary Neoplasms/pathology , Prolactin/therapeutic use , Receptors, Estrogen/therapeutic use , Tumor Suppressor Protein p53/therapeutic use , Vascular Endothelial Growth Factor A/therapeutic use
3.
Rev Endocr Metab Disord ; 23(3): 647-657, 2022 06.
Article in English | MEDLINE | ID: mdl-35344185

ABSTRACT

Differentiation of pituitary neuroendocrine tumor (PitNET) tissue from surrounding normal tissue during surgery is challenging. A number of fluorescent agents is available for visualization of tissue discrepancy, with the potential of improving total tumor resection. This review evaluates the availability, clinical and technical applicability of the various fluorescent agents within the field of pituitary surgery. According to PRISMA guidelines, a systematic review was performed to identify reports describing results of in vivo application of fluorescent agents. In this review, 15 publications were included. Sodium Fluorescein (FNa) was considered in two studies. The first study reported noticeable fluorescence in adenoma tissue, the second demonstrated the strongest fluorescence in non-functioning pituitary adenomas. 5-Aminolevulinic acid (5-ALA) was investigated in three studies. One study compared laser-based optical biopsy system (OBS) with photo-diagnostic filter (PD) and found that the OBS was able to detect all microadenomas, even when MRI was negative. The second study retrospectively analyzed twelve pituitary adenomas and found only one positive for fluorescence. The third investigated fifteen pituitary adenomas of which one displayed vague fluorescence. Indocyanine green (ICG) was researched in four studies with variable results. Second-Window ICG yielded no significant difference between functioning and non-functioning adenomas in one study, while a second study displayed 4 times higher fluorescence in tumor tissue than in normal tissue. In three studies, OTL38 showed potential in non-functioning pituitary adenomas. At present, evidence for fluorescent agents to benefit total resection of PitNETs is lacking. OTL38 can potentially serve as a selective fluorescent agent in non-functioning pituitary adenomas in the near future.


Subject(s)
Adenoma , Neuroendocrine Tumors , Pituitary Neoplasms , Adenoma/diagnosis , Adenoma/pathology , Adenoma/surgery , Fluorescent Dyes , Humans , Indocyanine Green , Neuroendocrine Tumors/diagnosis , Neuroendocrine Tumors/surgery , Pituitary Neoplasms/pathology , Pituitary Neoplasms/surgery , Retrospective Studies
4.
BMJ Open ; 11(10): e049109, 2021 10 07.
Article in English | MEDLINE | ID: mdl-34620658

ABSTRACT

INTRODUCTION: Achieving gross total resection and endocrine remission in pituitary neuroendocrine tumours (PitNET) can be challenging, especially in PitNETs with cavernous sinus (CS) invasion, defined as a Knosp grade of 3 or 4. A potential target to identify PitNET tissue is vascular endothelial growth factor A (VEGF-A), which expression is known to be significantly higher in PitNETs with CS invasion. METHODS AND ANALYSIS: The aim of this non-randomised, non-blinded, single centre, feasibility and dose-finding phase 1 trial is to determine the feasibility of intraoperative fluorescence imaging detection of PitNET tissue during endoscopic transsphenoidal surgery using the VEGF-A targeting optical agent bevacizumab-800CW (4, 5, 10 or 25 mg). Nine to fifteen patients with a PitNET with a Knosp grade of 3 or 4 will be included. Secondary objectives are: (1) To identify the optimal tracer dose for imaging of PitNET tissue during transsphenoidal surgery for further development in a phase 2 fluorescence molecular endoscopy trial. (2) To quantify fluorescence intensity in vivo and ex vivo with multidiameter single-fibre reflectance, single-fibre fluorescence (MDSFR/SFF) spectroscopy. (3) To correlate and validate both the in vivo and ex vivo measured fluorescence signals with histopathological analysis and immunohistochemical staining. (4) To assess the (sub)cellular location of bevacizumab-800CW by ex vivo fluorescence microscopy. Intraoperative, three imaging moments are defined to detect the fluorescent signal. The tumour-to-background ratios are defined by intraoperative fluorescence in vivo measurements including MDSFR/SFF spectroscopy data and by ex vivo back-table fluorescence imaging. After inclusion of three patients in each dose group, an interim analysis will be performed to define the optimal dose. ETHICS AND DISSEMINATION: Approval was obtained from the Medical Ethics Review Board of the University Medical Centre Groningen. Results will be disseminated through national and international journals. The participants and relevant patient support groups will be informed about the results. TRIAL REGISTRATION NUMBER: NCT04212793.


Subject(s)
Neuroendocrine Tumors , Pituitary Neoplasms , Bevacizumab , Endoscopy , Feasibility Studies , Humans , Neuroendocrine Tumors/surgery , Pituitary Neoplasms/diagnostic imaging , Pituitary Neoplasms/surgery , Vascular Endothelial Growth Factor A
5.
Spine (Phila Pa 1976) ; 46(3): 160-168, 2021 Feb 01.
Article in English | MEDLINE | ID: mdl-33093310

ABSTRACT

STUDY DESIGN: Single-center retrospective case series. OBJECTIVE: The purpose of this study was to assess the safety and accuracy of three-dimensional (3D)-printed individualized drill guides for pedicle and lateral mass screw insertion in the cervical and upper-thoracic region, by comparing the preoperative 3D surgical plan with the postoperative results. SUMMARY OF BACKGROUND DATA: Posterior spinal fusion surgery can provide rigid intervertebral fixation but screw misplacement involves a high risk of neurovascular injury. However, modern spine surgeons now have tools such as virtual surgical planning and 3D-printed drill guides to facilitate spinal screw insertion. METHODS: A total of 15 patients who underwent posterior spinal fusion surgery involving patient-specific 3D-printed drill guides were included in this study. After segmentation of bone and screws, the postoperative models were superimposed onto the preoperative surgical plan. The accuracy of the realized screw trajectories was quantified by measuring the entry point and angular deviation. RESULTS: The 3D deviation analysis showed that the entry point and angular deviation over all 76 screw trajectories were 1.40 ±â€Š0.81 mm and 6.70 ±â€Š3.77°, respectively. Angular deviation was significantly higher in the sagittal plane than in the axial plane (P = 0.02). All screw positions were classified as "safe" (100%), showing no neurovascular injury, facet joint violation, or violation of the pedicle wall. CONCLUSIONS: 3D virtual planning and 3D-printed patient-specific drill guides appear to be safe and accurate for pedicle and lateral mass screw insertion in the cervical and upper-thoracic spine. The quantitative 3D deviation analyses confirmed that screw positions were accurate with respect to the 3D-surgical plan.Level of Evidence: 4.


Subject(s)
Pedicle Screws , Spinal Fusion/methods , Surgery, Computer-Assisted/methods , Adult , Aged , Child , Female , Humans , Male , Middle Aged , Neck , Postoperative Period , Printing, Three-Dimensional , Retrospective Studies , Spine/surgery , Tomography, X-Ray Computed
6.
World Neurosurg ; 129: 148-156, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31150856

ABSTRACT

OBJECTIVE: To describe a new method for cranial reconstruction after posterior fossa craniectomy in the surgical treatment of Chiari 1 malformation through a technical note and presentation of 3 illustrative cases. METHODS AND MATERIALS: A virtual surgical planning workflow was established for planning posterior fossa decompression, designing the suboccipital reconstruction, and manufacturing a 3D-printed polymethylmethacrylate (PMMA) casting mold. The casting accuracy was assessed by conducting a phantom experiment, and clinical data were provided by means of 3 illustrative cases. RESULTS: The accuracy of implant fabrication was found to be excellent, particularly when PMMA is introduced into the mold in a malleable state. In all 3 clinical cases, the implants were fabricated and positioned with success. Postoperative analysis revealed that accurate placement was achieved, with only minor deviation from the preoperative plan. CONCLUSIONS: 3D virtual surgical planning provides feasible tools for the planning of posterior fossa decompression and intraoperative fabrication of accurate patient-specific suboccipital cranioplasty.


Subject(s)
Arnold-Chiari Malformation/surgery , Plastic Surgery Procedures/methods , Polymethyl Methacrylate , Printing, Three-Dimensional , Prostheses and Implants , Adult , Cranial Fossa, Posterior/surgery , Craniotomy , Female , Humans , Male , Middle Aged , Young Adult
7.
World Neurosurg ; 123: 453-463.e15, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30529595

ABSTRACT

BACKGROUND: Anterior thoracic spinal cord herniation (ATSCH) is a rare cause of progressive myelopathy. Early surgery is essential, but there is no agreement about the best surgical approach. OBJECTIVE: To identify factors that determine surgical results and to find evidence for the most favorable technique to correct ATSCH. METHODS: To find relevant literature, computed databases of PubMed, EMBASE, and ISI Web of Science were searched. The study comprised case reports published between 1974 and 2018, and the data set was completed with 12 cases treated in our own institute. Patient characteristics were analyzed following the principles of an individual participant data meta-analysis. RESULTS: Brown-Séquard-like neurologic deficit before surgery was associated with postoperative motor function improvement compared with patients with paraparesis (P = 0.04). In the univariate analysis, widening of the dura defect (WDD) was more prevalent among improved patients, whereas anterior dura patch and application of intraoperative neurophysiologic monitoring were not. In the multivariate analysis, the favorable association with WDD disappeared, which is explained by the dominant influence of a Brown-Séquard-like deficit on outcome. CONCLUSIONS: In general, postoperative results after surgery for ATSCH are favorable, with a high percentage of patients experiencing postoperative improvement. Postoperative motor function improvement is more likely to occur in patients with a Brown-Séquard-like neurologic deficit. The WDD should be favored above the application of a patch as the technique of choice in surgical treatment of ATSCH.


Subject(s)
Intervertebral Disc Displacement/complications , Intervertebral Disc Displacement/surgery , Spinal Cord Diseases/etiology , Thoracic Vertebrae/surgery , Treatment Outcome , Adult , Databases, Bibliographic , Disease Progression , Dura Mater/pathology , Female , Humans , Intervertebral Disc Displacement/diagnostic imaging , Male , Middle Aged , Paraparesis/etiology , Paraparesis/surgery , Thoracic Vertebrae/diagnostic imaging
8.
Neurology ; 84(18): 1894-903, 2015 May 05.
Article in English | MEDLINE | ID: mdl-25862799

ABSTRACT

OBJECTIVE: Spontaneous spinal epidural hemorrhage (SSEH) warrants urgent surgical treatment in most cases. Which patients will benefit most from decompression is not known and the disease's rarity hampers the collection of large data series to ascertain this. Therefore, using an individual patient data (IPD) meta-analysis, we aimed to identify predictors for outcome and to obtain knowledge on the etiology of SSEH. METHODS: The IPD meta-analysis is based on raw data from case reports across all studies concerning all variables of interest. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement was used. This led to a total of 741 unique pure SSEH patient cases from 487 journal articles. Data were extracted using a data extraction sheet and analyzed using a multivariable logistic regression model. RESULTS: A preoperative Frankel score of C and higher, absence of use of anticoagulants, compression of the cauda equina only, and the extension of the hematoma over 3 or 4 vertebral segments were associated with good outcome. Operative interval was not invariably associated with outcome and hypertension was not a risk factor for developing SSEH. CONCLUSIONS: Outcome is mainly determined by severity of preoperative neurologic deficit and use of anticoagulants. Evidence for a venous origin of SSEH is abundant in view of the observed anatomical distribution in different age categories and the absence of hypertension as an isolated risk factor.


Subject(s)
Cauda Equina/surgery , Hematoma, Epidural, Spinal/surgery , Nerve Compression Syndromes/surgery , Paraplegia/surgery , Spinal Cord Compression/surgery , Adult , Aged , Decompression, Surgical , Female , Hematoma, Epidural, Spinal/complications , Humans , Logistic Models , Male , Middle Aged , Multivariate Analysis , Nerve Compression Syndromes/etiology , Paraplegia/etiology , Prognosis , Spinal Cord Compression/etiology , Time Factors
9.
Spine J ; 14(9): 2038-41, 2014 Sep 01.
Article in English | MEDLINE | ID: mdl-24768747

ABSTRACT

BACKGROUND CONTEXT: Prediction models for outcome of decompressive surgical resection of spinal epidural metastases (SEM) have in common that they have been developed for all types of SEM, irrespective of the type of primary tumor. It is our experience in clinical practice, however, that these models often fail to accurately predict outcome in the individual patient. PURPOSE: To investigate whether decision making could be optimized by applying tumor-specific prediction models. For the proof of concept, we analyzed patients with SEM from renal cell carcinoma that we have operated on. STUDY DESIGN/SETTING: Retrospective chart analysis 2006 to 2012. PATIENT SAMPLE: Twenty-one consecutive patients with symptomatic SEM of renal cell carcinoma. OUTCOME MEASURES: Predictive factors for survival. METHODS: Next to established predictive factors for survival, we analyzed the predictive value of the Motzer criteria in these patients. The Motzer criteria comprise a specific and validated risk model for survival in patients with renal cell carcinoma. RESULTS: After multivariable analysis, only Motzer intermediate (hazard ratio [HR] 17.4, 95% confidence interval [CI] 1.82-166, p=.01) and high risk (HR 39.3, 95% CI 3.10-499, p=.005) turned out to be significantly associated with survival in patients with renal cell carcinoma that we have operated on. CONCLUSIONS: In this study, we have demonstrated that decision making could have been optimized by implementing the Motzer criteria next to established prediction models. We, therefore, suggest that in future, in patients with SEM from renal cell carcinoma, the Motzer criteria are also taken into account.


Subject(s)
Carcinoma, Renal Cell/surgery , Decompression, Surgical/methods , Epidural Neoplasms/surgery , Kidney Neoplasms/pathology , Spinal Cord Compression/surgery , Carcinoma, Renal Cell/complications , Carcinoma, Renal Cell/secondary , Cohort Studies , Decision Support Techniques , Disease-Free Survival , Epidural Neoplasms/complications , Epidural Neoplasms/secondary , Humans , Multivariate Analysis , Neurosurgical Procedures , Patient Selection , Prognosis , Proportional Hazards Models , Retrospective Studies , Spinal Cord Compression/etiology
10.
Ned Tijdschr Geneeskd ; 156(28): A4824, 2012.
Article in Dutch | MEDLINE | ID: mdl-22805793

ABSTRACT

Anterior thoracic transdural spinal cord herniation (ATTSCH) is a rare cause of slowly progressing thoracic myelopathy. The myelopathy is caused by herniation and subsequent trapping of the thoracic spinal cord through a defect in the anterior dural sac. We describe the case of a man, 38 years of age, who presented with a 4-year history of progressive pyramidal syndrome with sphincteral and erection disorders caused by ATTSCH. The patient underwent a surgical intradural exploration and release (detethering) of the spinal cord and reduction of the cord herniation; a polytetrafluoroethylene sleeve was inserted to cover the defect and to prevent the cord from reherniation. Anterior thoracic transdural spinal cord herniation is a treatable cause of myelopathy and early detection is of great importance to the prognosis. Because this condition is so rare and therefore, relatively unknown, delay in the diagnostic process and subsequent surgical treatment often occur.

11.
J Trauma Acute Care Surg ; 72(6): 1681-7, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22695441

ABSTRACT

BACKGROUND: In this retrospective study, we analyzed the outcomes of different types of treatment of fingertip injuries and compared them after a mean follow-up of 4.5 years. METHODS: A total of 53 patients (59 injuries) were included in this study. The fingertip injuries were classified according to Allen classification. The patients were categorized into three groups based on the treatment: reconstructive group, bone-shortening group, and conservative group. As objective assessments, strength, sensibility, and goniometry were measured; as subjective assessments, cold intolerance, nail deformation, and aesthetics were measured. RESULTS: The mean reduction in strength, the Semmes-Weinstein monofilament test, and the reduction in mobility for the injured fingers compared with those of the uninjured finger were not significantly different between the groups. Cold intolerance was reported in 50 (84.7%) of the 59 fingers, and in almost 90% of all the cases, there was some kind of nail distortion. For the cold intolerance and nail distortions, there was no difference between the groups. The aesthetic outcomes judged by patients and surgeon were comparable. CONCLUSION: In conclusion, the outcome of treatment of Allen II, III, and IV fingertip injuries was irrespective of the treatment chosen. In an era where the enormous variety of surgical options suggests that treatment with a flap is the best, this outcome is at least surprising. LEVEL OF EVIDENCE: Therapeutic study, level IV.


Subject(s)
Finger Injuries/diagnosis , Finger Injuries/surgery , Plastic Surgery Procedures/methods , Surgical Flaps/blood supply , Adult , Aged , Amputation, Traumatic/diagnostic imaging , Amputation, Traumatic/surgery , Analysis of Variance , Bone Lengthening/methods , Cohort Studies , Female , Follow-Up Studies , Humans , Injury Severity Score , Male , Middle Aged , Nails, Malformed/prevention & control , Radiography , Recovery of Function , Retrospective Studies , Risk Assessment , Soft Tissue Injuries/diagnostic imaging , Soft Tissue Injuries/surgery , Treatment Outcome , Wound Healing/physiology
12.
J Clin Neurosci ; 19(8): 1170-1, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22658242

ABSTRACT

Intracranial mesenchymal chondrosarcoma is a rare, high-grade malignancy with the highest prevalence in young adults. Because of its rarity, most data regarding survival are limited to case studies and small series. We present a 71-year-old woman with an intracranial dural based mesenchymal chondrosarcoma located in the anterior skull base, to our knowledge the oldest patient reported with this tumor.


Subject(s)
Bone Neoplasms/diagnosis , Chondrosarcoma, Mesenchymal/diagnosis , Dura Mater/pathology , Aged , Female , Humans , Magnetic Resonance Imaging , S100 Proteins/metabolism , Skull Base/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...